Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/25 21:05 | 6/10/25 | NTRA | Health | Health | Medical Laboratories | Marcus Gail Boxer | TX | D | 5 | S.d | -2,004 | 100.20 | 0 | -20 | 10 | D | ||||||||||||||||
6/4/25 21:05 | 6/2/25 | NTRA | Health | Health | Medical Laboratories | Moshkevich Solomon | TX | O | P,CLINIC | 5 | S | -1,722 | 149.70 | 0 | -12 | 142 | D | |||||||||||||||
6/4/25 21:05 | 6/2/25 | NTRA | Health | Health | Medical Laboratories | Chapman Steven Leonard | TX | DO | CEO,P | 7 | S.dm | -6,751 | 98.47 | 0 | -69 | 198 | D | |||||||||||||||
5/13/25 21:35 | 5/9/25 | NTRA | Health | Health | Medical Laboratories | Sheena Jonathan | TX | DH | CO-FOUND | 5 | S.dm | -1,872 | 145.65 | 0 | -13 | 336 | M | |||||||||||||||
4/30/25 21:35 | 4/28/25 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | 1 | S | -261 | 152.18 | 0 | -2 | 0 | 2,447 | D | ||||||||||||||
4/30/25 21:35 | 4/28/25 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Daniel | TX | O | SEC.,GC | 5 | S.d | -566 | 78.37 | 0 | -7 | 226 | D | |||||||||||||||
4/30/25 21:35 | 4/28/25 | NTRA | Health | Health | Medical Laboratories | Fesko John | TX | O | P,CHIEF | 2 | S | -310 | 151.07 | 0 | -2 | 157 | D | |||||||||||||||
4/30/25 21:35 | 4/28/25 | NTRA | Health | Health | Medical Laboratories | Brophy Michael Burkes | TX | O | CFO | 7 | S.dm | -1,542 | 79.40 | 0 | -19 | 76 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |